Upon admission, comprehensive diabetes management was initiated: subcutaneous injection of Novolog (preprandial) and Detemir insulin (at bedtime) for blood glucose control, along with dietary guidance, exercise education, and blood glucose monitoring; on the fourth day, it was adjusted to insulin pump therapy (continuous subcutaneous injection of insulin glargine R) to optimize glucose regulation. The gene discussed is INS; the disease is diabetes mellitus.